<DOC>
	<DOCNO>NCT02919332</DOCNO>
	<brief_summary>This clinical trial study well delay fludeoxyglucose F-18 ( 18F-FDG ) positron emission tomography ( PET ) /computed tomography ( CT ) work improve visualization brain tumor patient glioblastoma . Radiotracers 18F-FDG highly take tumor brain visualize use PET/CT . Increasing interval time 18F-FDG administration PET/CT scan may improve visualization brain tumor patient glioblastoma .</brief_summary>
	<brief_title>Delayed 18F-FDG PET/CT Improving Visualization Brain Tumors Patients With Glioblastoma</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To improve visualization/delineation glioblastoma lesion use delayed 18F-FDG PET/CT imaging . OUTLINE : Patients receive fludeoxyglucose F-18 intravenously ( IV ) . Patients undergo standard care PET/CT scan 60 minute second PET/CT scan 240 minute injection . Note : Standard Uptake Value ( SUV ) define state-of-the art PET/CT scanner Standardized uptake value = count activity per ml within region interest ( MBq/ml ) / [ inject dose ( MBq ) /body weight ( kgx1000 ) ]</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Patients histologically proven high grade glioma schedule 18FFDG PET/CT Severe psychiatric illness Inability give write consent Breast feeding/pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>